Treatments & Interventions
Fluoxetine hydrochloride
substance
Sertraline hydrochloride
substance
Paroxetine hydrochloride
substance
Venlafaxine hydrochloride
substance
Citalopram hydrobromide
substance
Fluvoxamine maleate
substance
Venlafaxine
substance
Sertraline
substance
Paroxetine
substance
Citalopram
substance
Fluoxetine
substance
Clomipramine
substance
Fluvoxamine
substance
Clomipramine hydrochloride
substance
Paroxetine mesylate
substance
Paroxetine hydrochloride anhydrous
substance
Paroxetine hydrochloride hemihydrate
substance
Signs & Symptoms
Based on Human Phenotype Ontology (HPO) disease-phenotype annotations.
Quick Facts
- SNOMED CT
- 191736004
- UMLS CUI
- C0028768
- Fully Specified Name
- Obsessive-compulsive disorder (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- HPO Phenotypes
- 5
- Known Treatments
- 17
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.